ArticleFrontiers in public health2026
Low follow-up rate after positive prostate cancer screening in southern China: a community-based cross-sectional survey with a prospective component.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Prostate cancer screening enables early detection of asymptomatic cases, but its public health impact depends on timely diagnostic evaluation after a positive result. However, follow-up rates after abnormal screening in community settings remain poorly characterized, particularly in underserved regions of China. This study aimed to investigate the follow-up rate and identify its determinants among men with positive prostate cancer screening results in a community-based cohort in Nanning, Guangxi, to inform targeted interventions. Design: Community-based cross-sectional survey with a 3-month prospective component. Methods: A cross-sectional study was conducted in a community in Nanning, Guangxi Zhuang Autonomous Region, from June to August 2021. Male residents aged ≥50 years (or ≥45 years with a family history of prostate cancer) who screened positive for prostate cancer (PSA > 4 μg/L) for the first time were eligible. Sociodemographic characteristics, clinical data, and psychosocial factors were collected through community health records and telephone interviews conducted 3 months after result notification. Follow-up was defined as attendance at a hospital for further evaluation within 3 months of receiving the screening result. Multivariate logistic regression was performed to identify factors associated with follow-up attendance. Results: A total of 2,939 participants underwent screening, of whom 278 (9.46%) tested positive. After excluding three cases with incomplete data, 275 men were included. Among them, 185 (67.3%) had PSA levels between 4-10 μg/L, and 90 (32.7%) had PSA > 10 μg/L. Only 81 participants (29.45%) attended a follow-up visit within 3 months. Multivariate logistic regression revealed that family awareness of the screening result (OR = 4.87, 95%CI: 1.81-13.10), presence of moderate-to-severe lower urinary tract symptoms (OR = 4.11, 95% CI: 2.14-7.89), and higher prostate cancer knowledge level (OR = 3.36, 95% CI: 1.78-6.36) were independently associated with increased odds of follow-up attendance (all Conclusion: The follow-up rate among men with positive prostate cancer screening results in this community-based Chinese cohort was alarmingly low (29.45%). Family awareness, lower urinary tract symptom severity, and disease-specific knowledge were identified as independent determinants of follow-up behavior. These findings highlight critical gaps in the screening-to-diagnosis continuum and underscore the need for targeted interventions-particularly those enhancing family involvement, improving symptom recognition, and increasing disease knowledge-to improve follow-up rates and ultimately optimize prostate cancer outcomes in community-based screening programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.